Editorial: Pathophysiological and clinical advances in asthmatic inflammation from the nasopharynx to the peripheral airway in the respiratory tract systems

Front Pharmacol. 2023 Jan 16:14:1037610. doi: 10.3389/fphar.2023.1037610. eCollection 2023.

Authors

Yasuhiko Koga¹, Yosuke Kamide², Takeshi Hisada³, Tamotsu Ishizuka⁴

Affiliations

¹ Department of Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
² Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
³ Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan.
⁴ Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

No abstract available

Keywords: benralizumab; eosinophilic chronic rhinosinusitis; leptin; metformin; non-coding RNA; omalizumab; severe asthma; type IV collagen.

Publication types

Editorial